Danger Zone – maybe.

OK – We’re going to try Ritalin.  Against the better judgement of my doc and me.  But it’s the only drug that produces the desired effect that I can afford.  It’s the side effect – the euphoria and the addictive potential that comes with it – that troubles me.

Hopefully it’ll be fine for 4 months untill the Provigil patient assistance program opens up again.

Cross your fingers.

  1. Be careful.
    I know you’re already not thrilled with the idea of taking either one and that’s a good thing. After 23 years in the program and watching my significant other fall on their ass (after 15 years in recovery)
    with catch phrases like:
    “the doctor’s monitoring me and knows I’m a recovering addict/alcoholic, so its okay” and
    “I’m doing less than what is prescribed and I’m fine” or
    “I HAVE to take (fill in the blank) at this point – I’m no martyr” and from watching too many members do the same, I just want to emphasize extreme caution. You don’t say why you were contemplating them (or I missed that posting), so I can’t say for sure. And even when it’s someone as close as my own partner, I cannot tell them what to do or not to do.
    Here’s what I do know:
    Drug Abuse And Dependence
    Controlled Substance Class

    “Modafinil (PROVIGIL) is listed in Schedule IV of the Controlled Substances Act…
    In addition to its wakefulness-promoting effect and increased locomotor activity in animals, in humans, PROVIGIL produces psychoactive and euphoric effects, alterations in mood, perception, thinking and feelings typical of other CNS stimulants. In in vitro binding studies, modafinil binds to the dopamine reuptake site and causes an increase in extracellular dopamine, but no increase in dopamine release. Modafinil is reinforcing, as evidenced by its self-administration in monkeys previously trained to self-administer cocaine. In some studies, modafinil was also partially discriminated as stimulant-like. Physicians should follow patients closely, especially those with a history of drug and/or stimulant (e.g., methylphenidate, amphetamine, or cocaine) abuse. Patients should be observed for signs of misuse or abuse (e.g., incrementation of doses or drug-seeking behavior).

    The abuse potential of modafinil (200, 400, and 800 mg) was assessed relative to methylphenidate (45 and 90 mg) in an inpatient study in individuals experienced with drugs of abuse. Results from this clinical study demonstrated that modafinil produced psychoactive and euphoric effects and feelings consistent with other scheduled CNS stimulants (methylphenidate).”

    *I have a family member who is not an addict who was prescribed this for narcolepsy and it a very potent drug.*

    “RITALIN® is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep RITALIN® in a safe place to prevent misuse and abuse. Selling or giving away RITALIN® may harm others, and is against the law.

    Tell your doctor if you have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines or street drugs.”

    Last thought:
    The disease of addiction is insidious. It worms its way in and permeates everything. Do what you need to for you, but do so with your eyes WIDE open, if you must. A couple of the lines crossed that unanimously were noted by people who relapsed were hiding what/how much was being taken & rationalizing stocking up/storing some against a time when it was not “needed”.

    Love ya, brother. Worry about ya and will say a little prayer for ya.

    Reply

  2. I’m not sure where you got your research, but when my doctor and I chose modafinil for treatment of ADHD we looked at this study, among others:

    1: Curr Psychiatry Rep. 2006 Oct;8(5):345-54.Links
    Management of methamphetamine abuse and dependence.
    Ling W, Rawson R, Shoptaw S, Ling W.

    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 11075 Santa Monica Boulevard, Suite 200, Los Angeles, CA 90025, USA. lwalter@ix.netcom.com

    Preliminary implications for evidence-based treatments and future practice may be drawn from new research findings that inspire a fresh view of methamphetamine dependence and associated medical consequences. Current user populations include increasingly impacted subgroups (ie, youths, women, men who have sex with men, and rural residents); complex consequences of methamphetamine abuse among these subgroups require additional efforts involving contextual understanding of characteristics and needs to develop effective treatments. The neurobiological data on cellular activity of methamphetamine taken with findings from neuroimaging studies indicate potential targets for pharmacologic interventions. In early trials, several candidate medications–bupropion, modafinil, and, to a lesser extent, baclofen–have shown promise in treating aspects of methamphetamine dependence, including aiding memory function necessary to more effectively participate in and benefit from behavioral therapies. Clinicians and researchers must interact to efficiently address the problems of methamphetamine dependence, a major drug problem in the United States and the world.

    By now modafinil is in phase 4 clinical trials at UCLA, MUSC, UNSW, and other research hospitals with open studies recruiting participants. “Methamphetamine dependence is a serious public health problem with no pharmacologic treatments currently available. Relapse rates are high in this population. Exposure to cues previously associated with methamphetamine use may induce profound craving in abstinent individuals. Chronic methamphetamine abuse is associated with selective cognitive deficits that may undermine successful participation in psychosocial treatments. Medications which improve cognitive deficits in methamphetamine-dependent individuals may improve abstinence rates, especially in the critical early period of recovery. Modafinil is an atypical stimulant medication with evidence to support its use in treating cocaine dependence and attention deficit/hyperactivity disorder. The proposed studies are designed to evaluate modafinil as a potential treatment for methamphetamine dependence and its cognitive sequelae.”

    Anecdotally I can tell you that it made a world of difference for me. I did really like how modafinil made me feel and function, but I never had a craving for it. I sometimes forgot to take it. When I did I was a little slow. 6 weeks without it and I am losing everything I put down and walking around the house, trying to find my shoe, which is in my hand.

    Thank you for taking the time to write and for your concern. I do appreciate it, despite my rebuttal.

    Reply

  3. you know, if you stay connected and remain open to feedback, you’ll be fine. i’ve learned i can work for change in my life. i have to.

    Reply

  4. good advise. like I said, the first call after the doc was my sponsor and there is very little I don’t spill here and there are people I see nearly every day who all know. They will see something wrong before I do and I just have to trust that.

    Reply

  5. I think your last statement truly sums up what you need to keep doing in order to make this work. Complete honesty is needed… with yourself most of all.

    Just be on the lookout for those thoughts that want you to withhold a detail, even one that seems insignificant, from your doctor, your sponsor, or us who read the site. That is truly the beginning of a backslide.

    You’ll do great.

    Reply

  6. Sounds to me if the Provigil didn’t make you relapse, the Ritalin won’t. But it may be a simple and smart precaution to let your sponser dole out your doses for the first weeks?
    Marc Rabins was in prison for the decade leading up to 2005. Did you bed him before 1995 then, or are you mistaken?

    Reply

  7. 1983-4 I don’t know that part of his story yet.

    Do you happen to know Ira Schlessinger?

    Reply

  8. Hi, I found your blog on this new directory of WordPress Blogs at blackhatbootcamp.com/listofwordpressblogs. I dont know how your blog came up, must have been a typo, i duno. Anyways, I just clicked it and here I am. Your blog looks good. Have a nice day. James.

    Reply

  9. 83-84? I forget others are as old as I.

    I’m trying to remember if the Ira I knew’s last name was Schlessinger. If he did ad sales at Genre, then yes, I knew him and still run into him occasionally in anonymous places.

    Reply

  10. ?? He’s a big volunteer at the Life Group LA

    Reply

Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

get userping